Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Avnet, Inc. | AVT | 911.55K | $80.96M |
MaxLinear, Inc. | MXL | 912.51K | $116.83M |
Prime Medicine, Inc. | PRME | 912.6K | $3.37M |
Ionis Pharmaceuticals, Inc. | IONS | 913.61K | $72.44M |
The J. M. Smucker Company | SJM | 914.28K | $102.86M |
Liberty Global plc | LBTYA | 914.41K | $10.4M |
DT Midstream, Inc. | DTM | 914.5K | $134.19M |
SEI Investments Company | SEIC | 914.91K | $80.25M |
Eni S.p.A. | E | 915.72K | $42.91M |
Regeneron Pharmaceuticals, Inc. | REGN | 916.47K | $571.45M |
Genmab A/S | GMAB | 916.6K | $25.18M |
Selective Insurance Group, Inc. | SIGI | 916.72K | $88.93M |
Lululemon Athletica Inc. | LULU | 916.98K | $104.7M |
IDEXX Laboratories, Inc. | IDXX | 918.14K | $483.34M |
Ryan Specialty Holdings, Inc. | RYAN | 918.85K | $34.7M |
Myriad Genetics, Inc. | MYGN | 918.86K | $5.25M |
Sweetgreen, Inc. | SG | 918.97K | $8.1M |
Brookfield Infrastructure Corporation | BIPC | 920.23K | $35.43M |
Ultragenyx Pharmaceutical Inc. | RARE | 920.31K | $30.73M |
News Corporation | NWS | 921.36K | $25.85M |